Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.25
Delayed Data
As of Jan 13
 +0.01 / +0.81%
Today’s Change
0.58
Today|||52-Week Range
1.76
+8.70%
Year-to-Date
No recent news for CASI Pharmaceuticals Inc.

Today’s Trading

Previous close1.24
Today’s open1.26
Day’s range1.21 - 1.26
Volume5,801
Average volume (3 months)63,751
Market cap$75.2M
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)+76.09%
Earnings growth (this year)-2.27%
Earnings growth (next 5 years)--
Revenue growth (last year)+101.09%
P/E ratioNM
Price/Sales652.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CEMIChembio Diagnostics ...+0.02+0.40%
INFIInfinity Pharmaceuti...+0.06+4.17%
PPHMPeregrine Pharmaceut...-0.00-0.34%
IPCIIntellipharmaceutics...-0.01-0.38%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateMarch 24, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$47.7K
Annual profit (last year)-$7.2M
Net profit margin-15,104.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ken Keyong Ren
COO, Secretary, Vice President &
General Counsel
Cynthia Wong Hu
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs